Menarini Asia-Pacific, a member of the world's largest Italian biopharmaceutical company, officially inaugurated the establishment of Menarini (China) Investment Co. Ltd. and the opening of its national headquarters on 29 October 2013 at the Wuhan National Bioindustry Base ("Wuhan Biolake") in Hubei Province, China.
Menarini is the largest Italian multinational biopharmaceutical company with over 16,000 employees worldwide and a presence in more than 100 countries, including Europe, Africa, Middle East, Asia-Pacific, Central and Latin America. With revenue in excess of USD3.46 Billion in 2016, Menarini ranks 19th among pharmaceutical companies in Europe and 39th among companies worldwide.
Menarini's aim is to conduct world class research and develop innovative medicines, making them available to patients all around the world.
Menarini was founded in 1886 and has developed into a global biopharmaceutical powerhouse with particular strengths in R&D, Manufacturing and Diagnostics, thus offering high quality healthcare solutions to doctors and patients. Menarini also possesses a strong tradition in partnering.
For more information about Menarini Group, visit www.menarini.com.